AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32357081 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum cortisol:cortisone ratio
Number of subjects: 269
Study 36282607 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketone supplement (7 g of beta-hydroxybutyrate, total of 14 g/d)
Number of subjects: 21
Study 36282607 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 33031169 — intervention group
Group type: EXPERIMENTAL
Intervention: Ambulatory blood pressure monitoring (ABPM)
Number of subjects: 146
Study 33031169 — intervention group
Group type: COMPARATOR
Intervention: Office blood pressure monitoring
Number of subjects: 146
Study 33095526 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular dexamethasone
Number of subjects: 2852
Study 33095526 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2852
Study 35210264 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab (162 mg per week)
Number of subjects: 36
Study 35210264 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 33186516 — intervention group
Group type: EXPERIMENTAL
Intervention: SF2a‐TT15 vaccine candidate (2 μg dose)
Number of subjects: 64
Study 33186516 — intervention group
Group type: EXPERIMENTAL
Intervention: SF2a‐TT15 vaccine candidate (10 μg dose)
Number of subjects: 64
Study 33186516 — intervention group
Group type: EXPERIMENTAL
Intervention: SF2a‐TT15 vaccine candidate (2 μg dose, adjuvanted with alum)
Number of subjects: 64
Study 33186516 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 33186516 — intervention group
Group type: EXPERIMENTAL
Intervention: SF2a‐TT15 vaccine candidate (adjuvanted and non-adjuvanted)
Number of subjects: 64
Study 33186516 — intervention group
Group type: EXPERIMENTAL
Intervention: SF2a‐TT15 vaccine candidate
Number of subjects: 64
Study 36411694 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese version of Critical Cultural Competence Scale (CCCS)
Number of subjects: 580
Study 36411694 — intervention group
Group type: EXPERIMENTAL
Intervention: Exploratory factor analysis
Number of subjects: 580
Study 36411694 — intervention group
Group type: EXPERIMENTAL
Intervention: Confirmatory factor analysis
Number of subjects: 580
Study 36411694 — intervention group
Group type: EXPERIMENTAL
Intervention: Reliability measures
Number of subjects: 580
Study 32075842 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal oxygenation (HFNO)
Number of subjects: 380
Study 32075842 — intervention group
Group type: COMPARATOR
Intervention: Standard oxygen therapy (SOT)
Number of subjects: 380
Study 35668472 — intervention group
Group type: COMPARATOR
Intervention: ECD intervention (individually and combined with IHIP)
Number of subjects: 317
Study 35668472 — intervention group
Group type: COMPARATOR
Intervention: IHIP intervention (individually and combined with ECD)
Number of subjects: 317
Study 33618403 — intervention group
Group type: EXPERIMENTAL
Intervention: CT scan planning (group 1)
Number of subjects: 50
Study 33618403 — intervention group
Group type: COMPARATOR
Intervention: Standard three degrees adjustment (group 2)
Number of subjects: 50
Study 33210382 — intervention group
Group type: EXPERIMENTAL
Intervention: NUC-1031 625 mg/m2 and cisplatin 25 mg/m2
Number of subjects: 21
Study 33210382 — intervention group
Group type: EXPERIMENTAL
Intervention: NUC-1031 725 mg/m2 and cisplatin 25 mg/m2
Number of subjects: 21
Study 36272450 — intervention group
Group type: EXPERIMENTAL
Intervention: Impella CP
Number of subjects: 0
Study 33253427 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane-remifentanil
Number of subjects: 60
Study 33253427 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane-fentanyl
Number of subjects: 60
Study 32732643 — intervention group
Group type: EXPERIMENTAL
Intervention: Text message intervention promoting help-seeking behaviors for 3 months
Number of subjects: 45
Study 36342237 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute normovolemic hemodilution (ANH)
Number of subjects: 197
Study 36342237 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 197
Study 36342237 — intervention group
Group type: EXPERIMENTAL
Intervention: ANH
Number of subjects: 197
Study 36342237 — intervention group
Group type: COMPARATOR
Intervention: ANH and Standard treatment
Number of subjects: 197
Study 33048421 — intervention group
Group type: EXPERIMENTAL
Intervention: Tasmannia lanceolata extract (TLE)
Number of subjects: 29
Study 33048421 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 32329438 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth technology and behavioral messages tailored to Patient Activation Measure (PAM) level at baseline
Number of subjects: 240
Study 32329438 — intervention group
Group type: COMPARATOR
Intervention: Control group (received equipment but not messaging)
Number of subjects: 240
Study 32329438 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 240
Study 35970940 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin (60 mg/day for 3 days)
Number of subjects: 15
Study 35970940 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 33805501 — intervention group
Group type: EXPERIMENTAL
Intervention: Participatory intervention to improve the psychosocial work environment and mental health.
Number of subjects: 0
Study 33805501 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined in the abstract).
Number of subjects: 0
Study 35229621 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured lifestyle modification intervention delivered by frontline health workers
Number of subjects: 12313
Study 35229621 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 12313
Study 34117699 — intervention group
Group type: EXPERIMENTAL
Intervention: Corneal crosslinking (CXL)
Number of subjects: 38
Study 34117699 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated eye)
Number of subjects: 38
Study 35325627 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month group-based multimodal physical activity programme (64 1-hour exercise sessions) and behavioural maintenance (21 45-minute sessions)
Number of subjects: 777
Study 35325627 — intervention group
Group type: COMPARATOR
Intervention: Brief advice (three healthy ageing education sessions)
Number of subjects: 777
Study 32968038 — intervention group
Group type: EXPERIMENTAL
Intervention: Technical modifications of the workstand
Number of subjects: 18
Study 32968038 — intervention group
Group type: EXPERIMENTAL
Intervention: Education based on practical training
Number of subjects: 18
Study 32968038 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural training
Number of subjects: 18
Study 32968038 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical training
Number of subjects: 18
Study 35459802 — intervention group
Group type: EXPERIMENTAL
Intervention: FAEV
Number of subjects: 94
Study 35459802 — intervention group
Group type: COMPARATOR
Intervention: EMA/CO
Number of subjects: 94
Study 33788439 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (EA) at Shaoshang (LU11) 30 minutes before anesthesia, and EA at Chize (LU5) and Hegu (LI4) during surgery
Number of subjects: 60
Study 33788439 — intervention group
Group type: COMPARATOR
Intervention: Control group (no electroacupuncture)
Number of subjects: 60
Study 34476476 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial 2 Arm C
Number of subjects: 418
Study 34476476 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial 1 Arm B
Number of subjects: 418
Study 34476476 — intervention group
Group type: COMPARATOR
Intervention: Eurocran dental index
Number of subjects: 418
Study 34476476 — intervention group
Group type: COMPARATOR
Intervention: 5YO index
Number of subjects: 418
Study 34476476 — intervention group
Group type: COMPARATOR
Intervention: GOSLON Yardstick
Number of subjects: 418
Study 34476476 — intervention group
Group type: COMPARATOR
Intervention: Orthodontic treatment
Number of subjects: 418
Study 35922101 — intervention group
Group type: EXPERIMENTAL
Intervention: Single 120-minute session of electronic Screening and Brief Intervention (SBI) for alcohol use in pregnancy.
Number of subjects: 0
Study 35922101 — intervention group
Group type: EXPERIMENTAL
Intervention: Single session plus two 5-minute boosters of electronic SBI.
Number of subjects: 0
Study 35922101 — intervention group
Group type: COMPARATOR
Intervention: None (no brief intervention).
Number of subjects: 0
Study 35922101 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored text messaging (none vs twice weekly messages).
Number of subjects: 0
Study 33012243 — intervention group
Group type: EXPERIMENTAL
Intervention: One-time hope intervention
Number of subjects: 292
Study 33012243 — intervention group
Group type: COMPARATOR
Intervention: Attention-matched progressive muscle relaxation intervention
Number of subjects: 292
Study 32176107 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous nursing care based on the Information, Knowledge, Attitude, and Practice (IKAP) theory
Number of subjects: 70
Study 32176107 — intervention group
Group type: COMPARATOR
Intervention: Standard nursing care (Control)
Number of subjects: 70
Study 32176107 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous nursing care based on the IKAP theory
Number of subjects: 70
Study 34918330 — intervention group
Group type: EXPERIMENTAL
Intervention: LGA infants
Number of subjects: 336
Study 34918330 — intervention group
Group type: COMPARATOR
Intervention: AGA infants
Number of subjects: 336
Study 34918330 — intervention group
Group type: EXPERIMENTAL
Intervention: Early solid feeding (<6 months)
Number of subjects: 336
Study 34918330 — intervention group
Group type: COMPARATOR
Intervention: Delayed solid feeding (≥6 months)
Number of subjects: 336
Study 35900355 — intervention group
Group type: EXPERIMENTAL
Intervention: Application explaining low GPA due to a mental health condition
Number of subjects: 99
Study 35900355 — intervention group
Group type: COMPARATOR
Intervention: Application explaining low GPA due to a physical health condition
Number of subjects: 99
Study 35900355 — intervention group
Group type: COMPARATOR
Intervention: Application with no explanation for low GPA
Number of subjects: 99
Study 34481498 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin and Linagliptin (E+L group)
Number of subjects: 97
Study 34481498 — intervention group
Group type: COMPARATOR
Intervention: Metformin and Insulin Glargine (M+I group)
Number of subjects: 97
Study 33332234 — intervention group
Group type: EXPERIMENTAL
Intervention: Infrared PBM group (IPG)
Number of subjects: 32
Study 33332234 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 32
Study 33332234 — intervention group
Group type: EXPERIMENTAL
Intervention: Red PBM group (RPG)
Number of subjects: 32
Study 36126199 — intervention group
Group type: EXPERIMENTAL
Intervention: Taping
Number of subjects: 31
Study 36126199 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 31
Study 32029163 — intervention group
Group type: EXPERIMENTAL
Intervention: Photostimulation at 16 weeks (PS16)
Number of subjects: 192
Study 32029163 — intervention group
Group type: EXPERIMENTAL
Intervention: Photostimulation at 18 weeks (PS18)
Number of subjects: 192
Study 32029163 — intervention group
Group type: EXPERIMENTAL
Intervention: Photostimulation at 20 weeks (PS20)
Number of subjects: 192
Study 32029163 — intervention group
Group type: EXPERIMENTAL
Intervention: Photostimulation at 22 weeks (PS22)
Number of subjects: 192
Study 35997273 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic stepwise PEEP strategy (DynPEEP) with 20 cmH2O maximum PEEP
Number of subjects: 65
Study 35997273 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic stepwise PEEP strategy (DynPEEP) with 14 cmH2O maximum PEEP
Number of subjects: 65
Study 35997273 — intervention group
Group type: COMPARATOR
Intervention: Positive pressure ventilation (PPV) at 8 cmH2O PEEP
Number of subjects: 65
Study 36064876 — intervention group
Group type: EXPERIMENTAL
Intervention: Lanthanum carbonate (LC)
Number of subjects: 239
Study 36064876 — intervention group
Group type: COMPARATOR
Intervention: Calcium carbonate (CC)
Number of subjects: 239
Study 33043684 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy for Body Image (IPT‐BI)
Number of subjects: 18
Study 35541985 — intervention group
Group type: EXPERIMENTAL
Intervention: Pranayama intervention (twice daily for 28 days)
Number of subjects: 250
Study 35541985 — intervention group
Group type: COMPARATOR
Intervention: Control group (normal daily routine, no pranayama)
Number of subjects: 250
Study 34489271 — intervention group
Group type: EXPERIMENTAL
Intervention: Speech and language therapy plus scalp acupuncture
Number of subjects: 203
Study 34489271 — intervention group
Group type: COMPARATOR
Intervention: Speech and language therapy alone
Number of subjects: 203
Study 32502040 — intervention group
Group type: EXPERIMENTAL
Intervention: Tuna-Hui-Chun-Gong (TNHCG) exercises
Number of subjects: 120
Study 32502040 — intervention group
Group type: COMPARATOR
Intervention: Standard COPD drugs
Number of subjects: 120
Study 33800392 — intervention group
Group type: EXPERIMENTAL
Intervention: SARS-CoV-2 infection assessment via PCR
Number of subjects: 535
Study 33800392 — intervention group
Group type: EXPERIMENTAL
Intervention: Specific IgG assessment via ELISA
Number of subjects: 535
Study 33800392 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of individual behavior and institutional infection prevention measures
Number of subjects: 535
Study 33800392 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to infection prevention measures
Number of subjects: 535
Study 35329869 — intervention group
Group type: EXPERIMENTAL
Intervention: Iloprost inhalation
Number of subjects: 40
Study 35329869 — intervention group
Group type: COMPARATOR
Intervention: Control (saline inhalation)
Number of subjects: 40
Study 32690737 — intervention group
Group type: EXPERIMENTAL
Intervention: Ayushman Bharat ‐ Pradhan Mantri Jan Arogya Yojana (AB ‐ PMJAY)
Number of subjects: 92
Study 32690737 — intervention group
Group type: COMPARATOR
Intervention: Public and private hospitals
Number of subjects: 92
Study 35045350 — intervention group
Group type: EXPERIMENTAL
Intervention: ALA-PDT
Number of subjects: 82
Study 33870587 — intervention group
Group type: EXPERIMENTAL
Intervention: IAN collagen‐membrane wrapping and interposing bone graft to overlay 23 implants
Number of subjects: 18
Study 33870587 — intervention group
Group type: COMPARATOR
Intervention: Conventional IANL in direct contact with 20 implants
Number of subjects: 18
Study 36108662 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab 200 mg administered intravenously every 3 weeks for up to 18 cycles
Number of subjects: 1177
Study 36108662 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered intravenously every 3 weeks for up to 18 cycles
Number of subjects: 1177
Study 36108662 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab 200 mg
Number of subjects: 1177
Study 36108662 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1177
Study 34077831 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose mycophenolate mofetil (≥ 2000 mg/day)
Number of subjects: 62
Study 34077831 — intervention group
Group type: COMPARATOR
Intervention: Low-dose mycophenolate mofetil (< 1000 mg/day)
Number of subjects: 62
Study 34077831 — intervention group
Group type: COMPARATOR
Intervention: Moderate-dose mycophenolate mofetil (1000 mg/day ≤ MMF dose < 2000 mg/day)
Number of subjects: 62
Study 34077831 — intervention group
Group type: COMPARATOR
Intervention: Patients with autoimmune diseases
Number of subjects: 62
Study 33398861 — intervention group
Group type: EXPERIMENTAL
Intervention: Buzzy device (experimental group)
Number of subjects: 56
Study 33398861 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Buzzy device)
Number of subjects: 56
Study 34871375 — intervention group
Group type: EXPERIMENTAL
Intervention: Tricuspid valve percutaneous repair strategy using a clip dedicated to the tricuspid valve
Number of subjects: 300
Study 34871375 — intervention group
Group type: COMPARATOR
Intervention: Best guideline-directed medical therapy
Number of subjects: 300
Study 34388107 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tranexamic acid (TXA)
Number of subjects: 65
Study 34388107 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 65
Study 32859887 — intervention group
Group type: EXPERIMENTAL
Intervention: Palliative primary tumor resection
Number of subjects: 0
Study 32859887 — intervention group
Group type: COMPARATOR
Intervention: No surgical resection of the primary tumor
Number of subjects: 0
Study 35441706 — intervention group
Group type: EXPERIMENTAL
Intervention: Triheptanoin
Number of subjects: 36
Study 35441706 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 33593938 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (congressional offices)
Number of subjects: 0
Study 33593938 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (researchers)
Number of subjects: 0
Study 33593938 — intervention group
Group type: COMPARATOR
Intervention: Control group (congressional offices)
Number of subjects: 0
Study 32047013 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamma3 nail (Stryker; proximally dynamic)
Number of subjects: 900
Study 32047013 — intervention group
Group type: EXPERIMENTAL
Intervention: Trigen Intertan nail (Smith & Nephew) in a dynamic lag screw configuration
Number of subjects: 900
Study 32047013 — intervention group
Group type: EXPERIMENTAL
Intervention: Trigen Intertan nail (Smith & Nephew) in a static lag screw configuration
Number of subjects: 900
Study 32047013 — intervention group
Group type: COMPARATOR
Intervention: Not specified
Number of subjects: 900
Study 35132582 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized marker method
Number of subjects: 0
Study 35132582 — intervention group
Group type: COMPARATOR
Intervention: Multiple imputation
Number of subjects: 0
Study 35132582 — intervention group
Group type: COMPARATOR
Intervention: Complete datasets
Number of subjects: 0
Study 35868416 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate pushing
Number of subjects: 1710
Study 35868416 — intervention group
Group type: COMPARATOR
Intervention: Intensive pushing
Number of subjects: 1710
Study 33446608 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dexamethasone (6 mg once daily for 4 days)
Number of subjects: 401
Study 33446608 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 401
Study 33446608 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dexamethasone
Number of subjects: 401
Study 32827290 — intervention group
Group type: EXPERIMENTAL
Intervention: NORTH STAR
Number of subjects: 24
Study 34921663 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine combined with Butorphanol (1 mg)
Number of subjects: 60
Study 34921663 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 60
Study 33032657 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 0
Study 33032657 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 0
Study 35760812 — intervention group
Group type: EXPERIMENTAL
Intervention: Heterologous booster of NVSI‐06‐08
Number of subjects: 1800
Study 35760812 — intervention group
Group type: COMPARATOR
Intervention: Homologous booster of BBIBP‐CorV
Number of subjects: 1800
Study 35760812 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (NVSI‐06‐08 and BBIBP‐CorV)
Number of subjects: 1800
Study 34130748 — intervention group
Group type: EXPERIMENTAL
Intervention: HT-delivered Brief Intervention (BI)
Number of subjects: 294
Study 34130748 — intervention group
Group type: COMPARATOR
Intervention: Informative leaflet
Number of subjects: 294
Study 32401307 — intervention group
Group type: EXPERIMENTAL
Intervention: Human milk oligosaccharides (HMOs)
Number of subjects: 153
Study 32401307 — intervention group
Group type: EXPERIMENTAL
Intervention: Factor 3 in colostrum
Number of subjects: 153
Study 32401307 — intervention group
Group type: EXPERIMENTAL
Intervention: Fucosyl‐disialyllacto‐N‐hexose (FDSLNH)
Number of subjects: 153
Study 33130213 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical Frailty Scale (CFS) in patients aged 65 years or older
Number of subjects: 255
Study 33130213 — intervention group
Group type: EXPERIMENTAL
Intervention: Age, chronic kidney disease, and previous stroke
Number of subjects: 255
Study 33130213 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 255
Study 33261645 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice protein (24g daily)
Number of subjects: 24
Study 33261645 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey protein (24g daily)
Number of subjects: 24
Study 36141561 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity exercise (HI, 85% VO2max, n = 10)
Number of subjects: 20
Study 36141561 — intervention group
Group type: COMPARATOR
Intervention: Moderate-intensity exercise (MI, 65% VO2max, n = 10)
Number of subjects: 20
Study 34718233 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporary uterine artery clamping
Number of subjects: 200
Study 34718233 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 200
Study 35020685 — intervention group
Group type: EXPERIMENTAL
Intervention: Orofacial treatment (physical therapy and occlusal splints)
Number of subjects: 80
Study 35020685 — intervention group
Group type: EXPERIMENTAL
Intervention: Orofacial treatment
Number of subjects: 80
Study 35020685 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in TMD pain
Number of subjects: 80
Study 35020685 — intervention group
Group type: COMPARATOR
Intervention: Control group (no other treatment)
Number of subjects: 80
Study 34351414 — intervention group
Group type: EXPERIMENTAL
Intervention: Aflibercept 2 mg every 16 weeks after 3 initial monthly doses (2q16 group)
Number of subjects: 402
Study 34351414 — intervention group
Group type: EXPERIMENTAL
Intervention: Aflibercept 2 mg every 8 weeks after 5 initial monthly doses with PRN dosing (2q8/PRN group)
Number of subjects: 402
Study 34351414 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined aflibercept groups
Number of subjects: 402
Study 34351414 — intervention group
Group type: COMPARATOR
Intervention: Control group (sham injections)
Number of subjects: 402
Study 34351414 — intervention group
Group type: EXPERIMENTAL
Intervention: Aflibercept 2 mg every 16 weeks (2q16 group)
Number of subjects: 402
Study 34351414 — intervention group
Group type: EXPERIMENTAL
Intervention: Aflibercept 2 mg every 8 weeks with PRN dosing (2q8/PRN group)
Number of subjects: 402